Drugs Made In America Acquisition (DMAAR) Debt Ratio (2024 - 2025)
Drugs Made In America Acquisition (DMAAR) posted Debt Ratio of 0.0 for Q1 2025, down 99.98% on a QoQ basis from 1.2 in Q4 2024.
Drugs Made In America Acquisition (DMAAR) Debt Ratio (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition's Debt Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q1 2025.
- Quarterly Debt Ratio changed N/A year-over-year to 0.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 0.0 (changed N/A YoY) and the FY2024 annual result came in at 1.2, changed N/A from the prior year.
- Debt Ratio was 0.0 for Q1 2025 at Drugs Made In America Acquisition, down from 1.2 in the prior quarter.
- Across five years, Debt Ratio topped out at 1.2 in Q4 2024 and bottomed at 0.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | - |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | 0.00 |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | - |
| 4 | Dynamix | 179.28 Mn | 179.28 Mn | - | - |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | - |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | - |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | - |
| 8 | Archimedes Tech SPAC Partners | 89.63 Mn | 89.63 Mn | - | - |
| 9 | Marblegate Capital | 81.65 Mn | 55.81 Mn | - | 0.06 |
| 10 | Drugs Made In America Acquisition | 1.41 Mn | 1.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 1.20 |